Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness.
about
Early rehabilitation in sepsis: a prospective randomised controlled trial investigating functional and physiological outcomes The i-PERFORM Trial (Protocol Article).Influence of exercise on the metabolic profile caused by 28 days of bed rest with energy deficit and amino acid supplementation in healthy menThe Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4.Sepsis and development impede muscle protein synthesis in neonatal pigs by different ribosomal mechanisms.Role of inhibitory κB kinase and c-Jun NH2-terminal kinase in the development of hepatic insulin resistance in critical illness diabetesCritical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases.TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle.Induction of muscle weakness by local inflammation: an experimental animal model.Exercise limitation following transplantation.Experimental Periodontitis in the Potentialization of the Effects of Immobilism in the Skeletal Striated Muscle.Physical activity, muscle strength, and exercise capacity 3 months after severe sepsis and septic shock.Plasma cytokine expression after lower-limb compression in rats.Effect of penetrating trunk trauma on the recovery of adult survivors: a pilot study.Exercise promotes IL-6 release from legs in older men with minor response to unilateral immobilization.Effects of neuromuscular electrical stimulation on cytokines in peripheral blood for healthy participants: a prospective, single-blinded Study.
P2860
Q34060869-D364572A-5742-4A6B-B4C4-6C612BF6012EQ34334204-A4EF6E6F-24DF-4F7C-9533-6993C725FB9EQ34483183-D5135656-B2F8-4901-9732-F0CD58F41BFDQ34523065-6960A278-FF2D-4797-ACED-44531BA47EB4Q34958917-045F6EEF-B6FA-4035-8D5F-0FD73199CE3AQ35216722-3FD8C097-FD97-44C2-8A4D-8C7A34869737Q36196647-3DCC8000-659A-49FC-8A18-3A3A57B6CD95Q36924162-5A1465A3-5BF6-4064-B805-F30F414C387DQ37467294-8059B54B-547A-4BC3-BA64-CC5E3A170A1CQ38110753-98908E0C-FCB3-4456-BE98-E4E89AB979F9Q38617839-23300E33-CB98-433C-9B98-44551F0B847AQ41141301-0C3686F2-2B21-464C-8845-F4B5637AEDF6Q41882152-E567787B-2223-44D4-8592-B306FC19E7E6Q45018092-D39344FD-EC36-441F-8EF4-FDE3C3DB4351Q51448085-50D228BC-1180-4ED3-860C-12B534A3FAFAQ52909174-15FB7882-01BB-439B-A91F-764FBECD5C38
P2860
Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inactivity and inflammation: s ...... ction during critical illness.
@ast
Inactivity and inflammation: s ...... ction during critical illness.
@en
type
label
Inactivity and inflammation: s ...... ction during critical illness.
@ast
Inactivity and inflammation: s ...... ction during critical illness.
@en
prefLabel
Inactivity and inflammation: s ...... ction during critical illness.
@ast
Inactivity and inflammation: s ...... ction during critical illness.
@en
P1476
Inactivity and inflammation: s ...... ction during critical illness.
@en
P2093
Chris Winkelman
P356
10.1097/00044067-200401000-00006
P407
P577
2004-01-01T00:00:00Z